Jane Street Group, LLC Esperion Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 222,786 shares of ESPR stock, worth $536,914. This represents 0.0% of its overall portfolio holdings.

Number of Shares

222,786

Previous 248,092 10.2%

Holding current value

$536,914

Previous $550,000 33.27%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.61 - $2.73 $40,742 - $69,085	-25,306 Reduced 10.2%	222,786 $367,000
Q2 2024 Aug 14, 2024	SELL	$1.84 - $3.24 $1.35 Million - $2.38 Million	-735,251 Reduced 74.77%	248,092 $550,000
Q1 2024 May 15, 2024	BUY	$2.02 - $3.02 $1.43 Million - $2.14 Million	707,696 Added 256.74%	983,343 $2.64 Million
Q4 2023 Feb 14, 2024	BUY	$0.73 - $3.08 $5,228 - $22,062	7,163 Added 2.67%	275,647 $824,000
Q3 2023 Nov 14, 2023	BUY	$0.96 - $1.79 $61,835 - $115,297	64,412 Added 31.56%	268,484 $263,000
Q2 2023 Aug 14, 2023	BUY	$1.2 - $1.76 $42,237 - $61,948	35,198 Added 20.84%	204,072 $283,000
Q1 2023 May 15, 2023	BUY	$1.46 - $7.3 $156,846 - $784,231	107,429 Added 174.84%	168,874 $268,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $195,099 - $325,805	38,330 Added 165.82%	61,445 $382,000
Q3 2022 Nov 14, 2022	SELL	$5.45 - $8.13 $12,387 - $18,479	-2,273 Reduced 8.95%	23,115 $155,000
Q3 2022 Nov 14, 2022	SELL	$5.45 - $8.13 $12,387 - $18,479	-2,273 Reduced 8.95%	23,115 $155,000
Q2 2022 Aug 16, 2022	BUY	$4.77 - $6.67 $52,379 - $73,243	10,981 Added 76.22%	25,388 $161,000
Q4 2021 Feb 15, 2022	SELL	$4.81 - $11.92 $8,008 - $19,846	-1,665 Reduced 10.36%	14,407 $72,000
Q3 2021 Nov 16, 2021	SELL	$11.34 - $21.37 $52,311 - $98,579	-4,613 Reduced 22.3%	16,072 $194,000
Q1 2021 May 18, 2021	SELL	$25.12 - $36.89 $177,924 - $261,291	-7,083 Reduced 25.51%	20,685 $580,000
Q4 2020 Feb 17, 2021	BUY	$24.2 - $35.76 $249,405 - $368,542	10,306 Added 59.02%	27,768 $722,000
Q3 2020 Nov 17, 2020	BUY	$31.18 - $52.71 $302,477 - $511,339	9,701 Added 125.0%	17,462 $649,000
Q2 2020 Aug 17, 2020	SELL	$30.04 - $51.31 $146,685 - $250,546	-4,883 Reduced 38.62%	7,761 $399,000
Q1 2020 May 15, 2020	SELL	$27.44 - $73.84 $597,698 - $1.61 Million	-21,782 Reduced 63.27%	12,644 $398,000
Q4 2019 Feb 14, 2020	BUY	$35.4 - $59.82 $881,283 - $1.49 Million	24,895 Added 261.2%	34,426 $2.05 Million
Q3 2019 Nov 14, 2019	BUY	$34.47 - $47.53 $328,533 - $453,008	9,531 New	9,531 $349,000
Q1 2019 May 16, 2019	SELL	$40.11 - $53.57 $214,949 - $287,081	-5,359 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$36.99 - $59.11 $225,417 - $360,216	-6,094 Reduced 53.21%	5,359 $247,000
Q3 2018 Nov 14, 2018	SELL	$40.74 - $51.41 $810,563 - $1.02 Million	-19,896 Reduced 63.47%	11,453 $508,000
Q4 2017 Feb 15, 2018	BUY	$43.47 - $67.43 $873,833 - $1.36 Million	20,102 Added 178.73%	31,349 $2.06 Million
Q3 2017 Nov 14, 2017	BUY	$43.8 - $52.77 $492,618 - $593,504	11,247	11,247 $564,000

Others Institutions Holding ESPR

# of Institutions

208

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $160M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Esperion Therapeutics, Inc. Transaction History